drug

Ketamine Hydrochloride

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Dr. Inge Winter
2 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

2
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
NCT05603104Phase 3Recruiting
Glutamatergic Mechanisms of Psychosis and Target Engagement (SA1)
NCT04589208Phase 1, Phase 2Suspended

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Dr. Inge Winter
company
trial
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
PHASE3
trial
Glutamatergic Mechanisms of Psychosis and Target Engagement (SA1)
PHASE1, PHASE2
trial
indication
Schizophrenia
indication
Healthy
indication
Bipolar Disorder
indication
Schizophrenia and Related Disorders
indication